None
EN
CU Anschutz Uncovers New Treatment Method for Alcohol Use Disorder
['The University Network', '.Wp-Block-Post-Author Box-Sizing Border-Box Display Flex Flex-Wrap Wrap .Wp-Block-Post-Author__Byline Font-Size Margin-Bottom Margin-Top Width', '.Wp-Block-Post-Author__Avatar Margin-Right .Wp-Block-Post-Author__Bio Font-Size Margin-Bottom .Wp-Block-Post-Author__Content Flex-Basis Flex-Grow .Wp-Block-Post-Author__Name Margin']
TUN
Scientists from the CU Anschutz School of Medicine have identified a new method to treat alcohol use disorder (AUD), using a drug that boosts dopamine in the prefrontal cortex, potentially offering a novel approach to managing the condition.
The University NetworkIn a groundbreaking study, researchers at the University of Colorado Anschutz School of Medicine have identified a new approach to treating alcohol use disorder (AUD).
Currently, AUD treatments function primarily in two ways: by reducing the euphoria associated with alcohol consumption or by lessening the cravings for alcohol.
Focus on the Prefrontal Cortex“The current medications for AUD target the neurotransmitter dopamine in the reward-related parts of the brain,” Schacht added.
They turned to tolcapone, an FDA-approved drug initially designed for Parkinson’s disease, which increases dopamine levels in the prefrontal cortex.